Showing results (41-50 of 115) with videos related to
Sort By:
Pageof 12
Journal of Neurology|March 31, 2018
Alpha-synuclein is present in dental calculus but not altered in Parkinson's disease patients in comparison to controlsSabrina Schmid, Eva Goldberg-Bockhorn, Silke Schwarz, et al.Neurology|May 15, 2023
CSF Synaptic Biomarkers in AT(N)-Based Subgroups of Lewy Body DiseaseLorenzo Barba, Samir Abu-Rumeileh, Steffen Halbgebauer, et al.Journal of Neurology, Neurosurgery, and Psychiatry|August 9, 2022
Cerebrospinal fluid β-synuclein as a synaptic biomarker for preclinical Alzheimer's diseaseLorenzo Barba, Samir Abu Rumeileh, Giovanni Bellomo, et al.ESC Heart Failure|May 25, 2022
Serum glial fibrillary acidic protein indicates memory impairment in patients with chronic heart failureJan Traub, Markus Otto, Roxane Sell, et al.Journal of Neurology|December 21, 2024
CSF synaptic biomarkers and cognitive impairment in multiple sclerosisLorenzo Barba, Lorenzo Gaetani, Silvia Sperandei, et al.Clinical Chemistry and Laboratory Medicine|February 14, 2024
Quantification of blood glial fibrillary acidic protein using a second-generation microfluidic assay. Validation and comparative analysis with two established assaysBadrieh Fazeli, Nerea Gómez de San José, Sarah Jesse, et al.Experimental Neurology|February 14, 2012
iTRAQ and multiple reaction monitoring as proteomic tools for biomarker search in cerebrospinal fluid of patients with Parkinson's disease dementiaStefan Lehnert, Sarah Jesse, Wolfgang Rist, et al.Journal of the Neurological Sciences|June 8, 2024
CSF neurosecretory proteins VGF and neuroserpin in patients with Alzheimer's and Lewy body diseasesLorenzo Barba, Giovanni Bellomo, Patrick Oeckl, et al.Annals of Clinical and Translational Neurology|August 23, 2023
Plasma β-synuclein, GFAP, and neurofilaments in patients with malignant gliomas undergoing surgical and adjuvant therapySamir Abu-Rumeileh, Lorenzo Barba, Matthias Bache, et al.Journal of Neurology, Neurosurgery, and Psychiatry|June 26, 2025
Serum level changes of the synaptic marker beta-synuclein in Alzheimer's disease continuum and other dementiasLorenzo Barba, Giovanni Bellomo, Daniel Alcolea, et al.Pageof 12